Icon

ONIVYDE (nda207793)- (EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML))

IRINOTECAN HYDROCHLORIDE IPSEN
EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML)
No Yes
2036-Oct-15 Expired
2022-Oct-22 2018-Oct-22
None No
ONIVYDE is a topoisomerase inhibitor indicated, in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.
0 0 0
Total Other Developers 7
Drugs with Suitability No
EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.